Evolent Health, Inc.
DE ˙ DB ˙ US30050B1017
3,38 € ↓ -0,16 (-4,52%)
2026-06-03
AKTIENPREIS
SecurityDE:9EH / Evolent Health, Inc.
InstitutionWells Fargo & Company/mn
Latest Disclosed Ownership50,700 shares
Latest Disclosed Value $ 115,596
Wells Fargo & Company/mn ownership in 9EH / Evolent Health, Inc.

On May 11, 2026 - Wells Fargo & Company/mn filed a 13F-HR form disclosing ownership of 50,700 shares of Evolent Health, Inc. (DE:9EH) valued at $95,823 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 136,524 shares of Evolent Health, Inc.. This represents a change in shares of -62.86% during the quarter. The current value of the position is $171,366 USD.

Wells Fargo & Company/mn has a history of taking positions in derivatives of the underlying security (9EH) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:9EH / Evolent Health, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F EVOLENT HEALTH CL A 30050B101 50,700 -85,824 -62.86 116 -78.94 0.0000
2026-02-13 2025-12-31 13F EVOLENT HEALTH CL A 30050B101 136,524 43,583 46.89 546 -30.53 0.0001
2025-11-13 2025-09-30 13F EVOLENT HEALTH CL A 30050B101 92,941 -306,453 -76.73 786 -82.52 0.0001
2025-08-14 2025-06-30 13F EVOLENT HEALTH CL A 30050B101 399,394 332,668 498.56 4,497 612.68 0.0009
2025-05-13 2025-03-31 13F EVOLENT HEALTH CL A 30050B101 66,726 -2,724 -3.92 632 -19.21 0.0001
2025-02-13 2024-12-31 13F EVOLENT HEALTH CL A 30050B101 69,450 -20,756 -23.01 781 -69.38 0.0002
2024-11-13 2024-09-30 13F EVOLENT HEALTH CL A 30050B101 90,206 -835 -0.92 2,551 46.61 0.0006
2024-08-13 2024-06-30 13F EVOLENT HEALTH CL A 30050B101 91,041 1,736 1.94 1,741 -40.57 0.0004
2024-05-10 2024-03-31 13F EVOLENT HEALTH CL A 30050B101 89,305 5,592 6.68 2,928 5.90 0.0007
2024-02-09 2023-12-31 13F EVOLENT HEALTH CL A 30050B101 83,713 3,531 4.40 2,765 26.66 0.0007
2023-11-13 2023-09-30 13F EVOLENT HEALTH CL A 30050B101 80,182 -45,240 -36.07 2,183 -42.55 0.0006
2023-08-15 2023-06-30 13F EVOLENT HEALTH CL A 30050B101 125,422 7,752 6.59 3,800 -0.47 0.0010
2023-05-12 2023-03-31 13F EVOLENT HEALTH CL A 30050B101 117,670 34,878 42.13 3,818 64.29 0.0011
2023-02-13 2022-12-31 13F EVOLENT HEALTH CL A 30050B101 82,792 -4,519 -5.18 2,325 -25.94 0.0007
2022-11-14 2022-09-30 13F EVOLENT HEALTH CL A 30050B101 87,311 -4,518 -4.92 3,138 11.32 0.0010
2022-08-12 2022-06-30 13F EVOLENT HEALTH CL A 30050B101 91,829 -111,452 -54.83 2,819 -57.06 0.0009
2022-05-16 2022-03-31 13F EVOLENT HEALTH CL A 30050B101 203,281 -60,091 -22.82 6,565 -9.91 0.0017
2022-02-14 2021-12-31 13F EVOLENT HEALTH CL A 30050B101 263,372 -38,036 -12.62 7,287 -22.01 0.0018
2021-11-15 2021-09-30 13F EVOLENT HEALTH CL A 30050B101 301,408 21,557 7.70 9,344 58.10 0.0021
2021-08-16 2021-06-30 13F EVOLENT HEALTH CL A 30050B101 279,851 -34,737 -11.04 5,910 -7.00 0.0013
2021-05-13 2021-03-31 13F EVOLENT HEALTH CL A 30050B101 314,588 -75,582 -19.37 6,355 1.60 0.0014
2021-02-09 2020-12-31 13F EVOLENT HEALTH CL A 30050B101 390,170 -76,186 -16.34 6,255 8.09 0.0015
2020-11-05 2020-09-30 13F EVOLENT HEALTH CL A 30050B101 466,356 35,066 8.13 5,787 88.44 0.0016
2020-08-13 2020-06-30 13F EVOLENT HEALTH CL A 30050B101 431,290 112,566 35.32 3,071 77.51 0.0009
2020-05-14 2020-03-31 13F EVOLENT HEALTH CL A 30050B101 318,724 -42,979 -11.88 1,730 -47.16 0.0006
2020-02-14 2019-12-31 13F EVOLENT HEALTH CL A 30050B101 361,703 -1,882 -0.52 3,274 25.20 0.0009
2019-11-12 2019-09-30 13F EVOLENT HEALTH CL A 30050B101 363,585 91,518 33.64 2,615 20.95 0.0007
2019-08-06 2019-06-30 13F EVOLENT HEALTH CL A 30050B101 272,067 -16,128 -5.60 2,162 -40.38 0.0006
2019-05-10 2019-03-31 13F EVOLENT HEALTH CL A 30050B101 288,195 -113,720 -28.29 3,626 -54.78 0.0011
2019-02-11 2018-12-31 13F EVOLENT HEALTH CL A 30050B101 401,915 69,616 20.95 8,019 -15.03 0.0027
2018-11-02 2018-09-30 13F EVOLENT HEALTH CL A 30050B101 332,299 -11,472 -3.34 9,437 30.40 0.0027
2018-08-01 2018-06-30 13F EVOLENT HEALTH CL A 30050B101 343,771 -52,072 -13.15 7,237 28.29 0.0021
2018-05-02 2018-03-31 13F EVOLENT HEALTH CL A 30050B101 395,843 37,657 10.51 5,641 28.03 0.0017
2018-02-08 2017-12-31 13F EVOLENT HEALTH CL A 30050B101 358,186 151,038 72.91 4,406 19.50 0.0013
2017-11-09 2017-09-30 13F EVOLENT HEALTH CL A 30050B101 207,148 -552,576 -72.73 3,687 -80.86 0.0011
2017-08-10 2017-06-30 13F EVOLENT HEALTH CL A 30050B101 759,724 668,066 728.87 19,259 842.22 0.0062
2017-04-28 2017-03-31 13F EVOLENT HEALTH CL A 30050B101 91,658 75,720 475.09 2,044 769.79 0.0007
2017-02-01 2016-12-31 13F EVOLENT HEALTH CL A 30050B101 15,938 6,708 72.68 235 3.52 0.0001
2016-10-31 2016-09-30 13F EVOLENT HEALTH CL A 30050B101 9,230 -1,057,917 -99.14 227 -98.89 0.0001
2016-08-11 2016-06-30 13F EVOLENT HEALTH CL A 30050B101 1,067,147 180,809 20.40 20,490 118.89 0.0079
2016-05-16 2016-03-31 13F EVOLENT HEALTH CL A 30050B101 886,338 77,429 9.57 9,361 -4.44 0.0037
2016-02-09 2015-12-31 13F EVOLENT HEALTH CL A 30050B101 808,909 145,685 21.97 9,796 -7.45 0.0039
2015-11-13 2015-09-30 13F EVOLENT HEALTH CL A 30050B101 663,224 94,034 16.52 10,585 -4.63 0.0044
2015-08-14 2015-06-30 13F EVOLENT HEALTH CL A 30050B101 569,190 569,190 11,099 0.0043
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-11-15 2021-09-30 13F EVOLENT HEALTH CL A Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F EVOLENT HEALTH CL A Put 9,300 196 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.